Efficacy and safety of Nirmatrelvir/Ritonavir for treating the Omicron variant of COVID-19

OBJECTIVE: To evaluate the efficacy and safety of Nirmatrelvir/Ritonavir in the treatment of the Omicron variant of coronavirus disease 2019 (COVID-19). METHODS: Data from 58 patients who were infected with the Omicron variant of COVID-19 were retrospectively collected. The patients were divided int...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Chaochao, Wu, Zhengxing, Liu, Xiaojing, Zhang, Qiang, Wu, Lianpeng, Ye, Xinchun, Zhou, Jiajun, Shi, Jichan, Jiang, Xiangao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373876/
https://www.ncbi.nlm.nih.gov/pubmed/37521354
http://dx.doi.org/10.3389/fmed.2023.1161193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373876/
https://www.ncbi.nlm.nih.gov/pubmed/37521354
http://dx.doi.org/10.3389/fmed.2023.1161193

Ejemplares similares